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Members of the sirtuin (SIRT) family of NAD-depen-
dent deacetylases promote longevity in multiple
organisms. Deficiency of mammalian SIRT6 leads to
shortened life span and an aging-like phenotype in
mice, but the underlying molecular mechanisms are
unclear. Here we show that SIRT6 functions at chro-
matin to attenuate NF-kB signaling. SIRT6 interacts
with the NF-kB RELA subunit and deacetylates
histone H3 lysine 9 (H3K9) at NF-kB target gene
promoters. In SIRT6-deficient cells, hyperacetylation
of H3K9 at these target promoters is associated with
increased RELA promoter occupancy and enhanced
NF-kB-dependent modulation of gene expression,
apoptosis, and cellular senescence. Computational
genomics analyses revealed increased activity of
NF-kB-driven gene expression programs in multiple
Sirt6-deficient tissues in vivo.Moreover, haploinsuffi-
ciency of RelA rescues the early lethality and degen-
erative syndromeof Sirt6-deficientmice.Wepropose
that SIRT6 attenuates NF-kB signaling via H3K9
deacetylation at chromatin, and hyperactive NF-kB
signaling may contribute to premature and normal
aging.
INTRODUCTION
The sirtuin (SIRT) family of nicotinamide adenine dinucleotide
(NAD)-dependent protein deacetylases is implicated in life span
regulation in yeast, worms, and flies (Haigis and Guarente,
2006). In mammalian genomes, there are seven SIRT genes
(SIRT1–SIRT7). Inactivation of the Sirt6 gene in mice leads to
dramatically shortened life span and a premature aging-like
phenotype (Mostoslavsky et al., 2006). Specifically, Sirt6-
deficient animals develop normally for several weeks after birth,62 Cell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc.but succumb to an acute multiorgan degenerative syndrome
that is uniformly lethal by 1monthof age. Thisphenotype includes
bonemineral density defects reminiscent of osteoporosis, spinal
curvature abnormalities, loss of subcutaneous fat, lymphocyte
attrition, and severe metabolic defects with precipitous drops in
serum glucose and IGF-1 levels (Mostoslavsky et al., 2006). In
addition, Sirt6-deficient mouse cells are hypersensitive to certain
forms of DNA damage and show increased genomic instability
(Mostoslavsky et al., 2006). However, relatively little was under-
stood regarding the fundamental molecular activity of SIRT6
and the cellular pathways in which it functions. Recently, we
discovered that SIRT6 is a histone H3 lysine 9 (H3K9) deacety-
lase, and identified a role for this SIRT6 activity at telomeric
chromatin, where it prevents telomere dysfunction in human cells
(Michishita et al., 2008). However, telomere dysfunction is not
observed in Sirt6-deficient mouse cells (Michishita et al., 2008),
and the molecular pathways that contribute to the phenotypes
of Sirt6/ mice remain unclear. It is also unknown whether
SIRT6 deacetylates H3K9 at genomic loci beyond telomeres, or
whether it regulates other chromatin-templated processes.
Thus, much remains to be discovered regarding the molecular
basis of SIRT6 action.
Another emerging modulator of aging-related pathways in
mammals is the NF-kB family of transcription factors, which
controls the activity of genes involved in apoptosis, cell senes-
cence, inflammation, and immunity (reviewed by Adler et al.,
2008; Hayden and Ghosh, 2008). NF-kB target gene activities
increase with age in many mammalian tissues and in stem cells
(Adler et al., 2007; Chambers et al., 2007; Helenius et al., 1996;
Korhonen et al., 1997). Moreover, blockade of NF-kB in the skin
of aged mice can reverse the global gene expression program
and tissue characteristics to that of younger animals (Adler
et al., 2007). NF-kB is also implicated in age-dependent induction
of cellular senescence in epithelial and hematopoietic progenitor
cells (Adler et al., 2007; Chambers et al., 2007). Therefore, NF-kB
appears to be an important regulator of aging-related cellular
processes.
NF-kB activity is controlled by multiple layers of regulation (re-
viewed byHayden andGhosh, 2008). There are five NF-kB family
members, each of which contains a Rel-homology DNA binding
domain. These NF-kB proteins typically bind to their target DNA
sequences as dimers. In unstimulated cells, NF-kB is seques-
tered in the cytoplasm by inhibitory IkB proteins. Upon stimula-
tion by diverse cell stresses (such as cytotoxic cytokine TNF-a,
oxidative stress, DNA damage, or infection), IkBs are degraded,
allowing NF-kB to translocate into the nucleus and activate
target genes. NF-kB induces the transcription of IkBa and other
negative regulators of the pathway (Hayden and Ghosh, 2008)
which contribute to signal inactivation. Thus, in individual cells,
NF-kB signaling is characterized by dynamic patterns of periodic
NF-kB nuclear localization and target gene activation inter-
spersed with nuclear exit and gene deactivation. Chromatin
regulation likely plays an important role in modulating NF-kB
target gene expression patterns. For example, certain NF-kB
target genes are primed whereas others are prevented from
reactivation following a pioneering round of NF-kB activity, and
these effects are associated with distinct chromatin modifica-
tions at the target genes (Foster et al., 2007). Additional factors
that control chromatin dynamics in NF-kB regulation remain to
be explored.
Given the intriguing links of both SIRT6 and NF-kB to aging-
associated processes, we hypothesized that these two path-
ways may functionally interact. Here we report that SIRT6 binds
to the NF-kB subunit RELA and attenuates NF-kB signaling by
modifying chromatin at NF-kB target genes. Genetic and
genomic studies further reveal that SIRT6-mediated control of
NF-kB prevents aging-associated, hyperactive NF-kB-depen-
dent gene expression, and inhibition of NF-kB can rescue the
early lethality of Sirt6 knockout mice.
RESULTS
SIRT6 Interacts Physically with the NF-kB Subunit RELA
To probe a potential connection between SIRT6 and NF-kB, we
askedwhether SIRT6 physically interacts with the NF-kB subunit
RELA. FLAG-tagged SIRT6 or several other mammalian SIRT
proteins were expressed in 293T cells and immunoprecipitated
with anti-FLAG antibodies. Western analysis of the immunopre-
cipitates (IPs) revealed that RELA associates with FLAG-SIRT6
(Figure 1A). Other FLAG-tagged SIRTs did not associate signifi-
cantly with RELA under these conditions. The interaction
between FLAG-SIRT6 and RELA is not due to DNA bridging,
because it is resistant to ethidium bromide (see Figure S1 avail-
able online). Western analysis of endogenous SIRT6 IPs also
revealed a specific interaction with RELA (Figure 1B), but not
other NF-kB family members (Figure S1) and, conversely,
SIRT6 was detected in IPs of endogenous RELA (Figure S1).
We note that on long exposures, the previously reported interac-
tion between RELA and SIRT1 (Yeung et al., 2004) was also
observed, but much more weakly than the RELA-SIRT6 interac-
tion (data not shown). Notably, the SIRT6-RELA interaction was
augmented by TNF-a stimulation (Figure 1C), suggesting that
TNFa-dependent translocation of RELA to the nucleus facilitates
its interaction with SIRT6, a predominantly nuclear protein.
In vitro pull-down assays using purified GST fusion proteins
revealed a specific interaction between GST-SIRT6 and in vitro
translated (IVT) RELA (Figure 1D), and between a GST-RELAprotein and IVT SIRT6 (Figure 1E), suggesting that the SIRT6-
RELA interaction is direct. Together, the data indicate that
SIRT6 interacts physically with RELA in vitro and in cells.
SIRT6 Is Recruited to NF-kB Target Gene Promoters
The TNF-a-inducible physical interaction between SIRT6 and
RELA suggested that SIRT6 might associate with promoters of
RELA target genes. To test this possibility, HeLa cells stably
expressing FLAG-tagged SIRT6 protein, or empty vector control,
were stimulatedwith TNF-a, and chromatin immunoprecipitation
(ChIP) was performed with anti-FLAG antibodies. In response to
TNF-a, FLAG-SIRT6 was detected at the promoters of several
NF-kB target genes, including IAP2, MnSOD, ICAM, and
NFKBIA (Figure 2A; data not shown). We then assessed occu-
pancy of endogenous SIRT6 at these promoters by ChIP anal-
ysis using SIRT6 antibodies, compared to IgG negative control
background signals. Again, TNF-a led to increased levels of
SIRT6 occupancy at these RELA target promoters (Figure 2B).
We note that SIRT6 expression levels do not change under these
conditions, and thus cannot account for the TNF-a-dependent
increase in the SIRT6 ChIP (Figure S1). To determine whether
SIRT6 is recruited to these genomic targets via its interaction
with RELA, we used short hairpin RNAs (shRNAs) to knock
down RELA expression (Figure 2C). This depletion of RELA abol-
ished the TNF-a-induced occupancy of SIRT6 at the RELA target
promoters (Figure 2D). Similar results were observedwhen RELA
was inactivated using siRNAs targeting an independent RELA
sequence (Figure S2) and in RelA knockout mouse cells (Fig-
ure S3). Together, these data suggest that SIRT6 is recruited to
chromatin at the promoters of RELA target genes, via its physical
interaction with RELA.
SIRT6 Represses NF-kB Target Gene Expression
The association of SIRT6 with RELA target promoters suggested
that SIRT6 levels might influence RELA-dependent transcription.
Therefore, we tested the effects of overexpressing SIRT6 or
several other SIRTs on expression of an NF-kB-luciferase
reporter gene. Only SIRT6 and SIRT1 significantly repressed
NF-kB reporter gene activity, whereas catalytically inactive
SIRT6 and SIRT1 mutant proteins did not (Figure 3A). To deter-
mine whether endogenous SIRT6 regulates NF-kB transcrip-
tional activity, we stably knocked down SIRT6 expression in
HeLa cells using two independent short hairpin RNAs that
were previously validated for specific targeting of SIRT6 (Fig-
ure 3B) (Michishita et al., 2008). SIRT6 depletion led to constitu-
tive NF-kB reporter gene activity, which, upon TNF-a treatment,
was further enhanced to levels considerably higher than in
SIRT6-proficient control cells (Figure 3C). SIRT6 depletion also
endowed exogenous RELA with higher transcriptional potency
(Figure 3D).
To determine whether SIRT6 regulates endogenous RELA-
dependent gene expression, we compared the expression of
multiple NF-kB target genes in SIRT6 knockdown and control
cells by quantitative RT-PCR. In control cells, TNF-a treatment
led to inducible expression of NF-kB target genes, as expected
(Figure 3E). The time course of this expression varied for specific
genes, consistent with previous reports (Hoffmann et al., 2002).
SIRT6 knockdown with both shRNAs led to superinduction ofCell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc. 63
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Figure 1. SIRT6 Interacts with RELA
(A) Coimmunoprecipitation of RELA with FLAG-tagged SIRT6 protein. Western blot (WB) analysis reveals RELA protein in immunoprecipitates (IP) of FLAG-
tagged SIRT6, but not several other SIRTs, expressed in 293T cells. A very weak interaction with SIRT7 may be observed under these conditions.
(B) Endogenous SIRT6 and RELA proteins interact. Western blot analysis of RELA following co-IP with endogenous SIRT6 or SIRT1, or control IP is shown.
(C) SIRT6-RELA interaction is induced upon TNF-a treatment. Endogenous co-IP of RELA with SIRT6 from 293T cells following TNF-a (20 ng/ml) treatment.
(D) In vitro translated RELA binds purified recombinant SIRT6-GST.
(E) In vitro translated SIRT6 binds purified recombinant GST-RELA (amino acids 1–431).a subset of NF-kB target genes, including IAP2, MnSOD2,
ICAM1, and NFKBIA (Figure 3E; Figure S4). Moreover, the
increased expression of RELA target genes that occurs with
SIRT6 knockdown was abolished in cells depleted of RELA,
demonstrating that these effects are not due to RELA-indepen-
dent effects of SIRT6 on gene expression (Figure S4).
Intriguingly, the SIRT6-repressed NF-kB target genes overlap
with genes that are increasingly expressedwith age, as assessed
by a compendium of 294 microarrays of global gene expression
changes that occur with age in six human tissues (Adler et al.,
2007) (Figure 3F; p = 0.001, hypergeometric distribution). For
example, IAP2, MnSOD, ICAM1, NFKBIA, and NFKB1 are all
induced with age in one or more human tissues. Together, our
results suggest that SIRT6 directly inhibits expression of a subset
of NF-kB target genes, especially those associated with aging.64 Cell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc.SIRT6 Deacetylates Histone H3 Lysine 9 on Promoters
of NF-kB Target Genes to Destabilize NF-kB
We recently showed that SIRT6 is a specific histoneH3K9deace-
tylase that modulates chromatin structure at telomeres (Michi-
shita et al., 2008). In the context of gene expression, acetylated
H3K9 (H3K9Ac) is associated with actively transcribed genes,
whereas H3K9 deacetylation correlates with gene repression
(Kouzarides, 2007). Therefore, we asked whether SIRT6 is
required for deacetylation of H3K9 at NF-kB target genes. ChIP
analysis revealed that H3K9 acetylation is induced following
TNF-a treatment in SIRT6-proficient control cells at the
promoters of multiple NF-kB target genes (Figure 4B), consistent
with transcriptional induction. In cells depleted of SIRT6 (Fig-
ure 4A), H3K9 was hyperacetylated at these promoters in
response to TNF-a (Figure 4B). A similar hyperacetylation of
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Figure 2. RELA Recruits SIRT6 to Target Promoters
(A) FLAG-SIRT6 is recruited to promoters of NF-kB target genes. HeLa cells stably expressing either pBabe-FLAG-SIRT6 or empty pBabe vector were treated
with TNF-a (20 ng/ml) for 45 min. ChIP with a-FLAG antibodies was performed, and FLAG-SIRT6 occupancy (mean ± SE) is shown relative to background signals
in ChIPs from pBabe control cells.
(B) Endogenous SIRT6 is recruited to the promoters of NF-kB target genes. HeLa cells were treated with TNF-a (20 ng/ml) for 45 min. ChIP with a-SIRT6
antibodies was performed, and SIRT6 occupancy (mean ± SE) is shown relative to background signals in IgG negative control ChIPs.
(C) Western analysis of RELA protein in HeLa cells stably expressing RELA shRNA (RELA sh).
(D) RELA is required for recruitment of SIRT6 to the promoters of NF-kB target genes. Cells were transduced with either RELA shRNA or control pSR vector
and treated with TNF-a (20 ng/ml) for 1 hr. ChIP with a-SIRT6 antibodies was performed and SIRT6 occupancy (mean ± SE) relative to untreated pSR control
cells is shown.H3K9 was observed in Sirt6 knockout mouse cells (Figure S3). In
contrast, no hyperacetylationwas observed at other histone resi-
dues in SIRT6-deficient cells, consistent with the specificity of
SIRT6 for H3K9Ac (Figure S2). Together, these data suggest
that SIRT6 is recruited to promoters of NF-kB target genes to
deacetylate H3K9.
Because histone deacetylation is proposed to decrease the
accessibility of chromatin to DNA binding factors (Kouzarides,
2007), we reasoned that SIRT6-mediated deacetylation of
H3K9 might contribute to destabilization of RELA at promoters
of NF-kB target genes. Therefore, we examined the effects of
SIRT6 depletion on RELA occupancy at target gene promoters
following TNF-a stimulation by ChIP. In SIRT6-depleted cells,
RELA occupancy at these promoters was significantly enhanced
and prolonged (Figure 4C; Figure S2). Similar effects were
observed in Sirt6 knockout mouse cells (Figure S3). This effect
was not due to delayed synthesis of IkBa because IkBa is a direct
NF-kB target gene, and in fact reaccumulates more rapidly in
SIRT6-depleted cells (Figure S5). To further investigate the possi-bility that deacetylation of H3K9 by SIRT6 destabilizes RELA at
chromatin, we carried out in vitro analyses to compare RELA
association with acetylated nucleosomes versus nucleosomes
that were deacetylated by SIRT6. In vitro nucleosome binding
assays revealed a strong interaction of RELA with purified,
acetylated nucleosomes, whereas much less RELA bound to
nucleosomes following deacetylation of H3K9 by SIRT6 (Figures
4D and 4E). Collectively, these results suggest that SIRT6-
mediated deacetylation of H3K9 promotes RELA destabilization
from target gene chromatin and termination of NF-kB signaling.
SIRT6 Depletion Elevates Apoptotic Resistance
and Induction of Senescence via NF-kB
We next examined whether known NF-kB cellular functions are
affected by SIRT6 depletion and, if so, whether this is dependent
on NF-kB. NF-kB activity is associated with increased resistance
to apoptosis and increased cellular senescence (Adler et al.,
2007; Hardy et al., 2005; Hayden and Ghosh, 2004). Consistent
with the observed induction of antiapoptotic genes by SIRT6Cell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc. 65
depletion (Figure 3), SIRT6 knockdown cells were more resistant
to apoptosis induced by the death adaptor protein FADD
(Figure 5A). This effect of SIRT6 depletion was reversed by coex-
pression of the super-repressor IkB-aM (Van Antwerp et al.,
1996), indicating that the apoptosis resistance requires NF-kB
(Figure 5A). We also probed a potential functional interplay
between SIRT6 and NF-kB in stress-induced senescence of
primary human keratinocytes, which occurs spontaneously in
ex vivo culture (Sherr and DePinho, 2000). SIRT6 knockdown
significantly increased senescence of primary keratinocytes,
and this effect was reversed by depletion of RELA by RNAi
(Figures 5B–5D). In contrast, NF-kB inhibition did not relieve
Figure 3. SIRT6 Represses RELA Target
Gene Expression
(A) SIRT6 and SIRT1 repress NF-kB transcriptional
activity. Top: relative luciferase units (RLU) of
RELA-mediated transcription of IL1-Luc (NF-kB
reporter gene) activity upon transfection of
FLAG-tagged SIRT proteins or vector control
(mean ± SE). *p < 0.05, Student’s t test. Bottom:
immunoblot showing expression of FLAG-tagged
SIRT proteins.
(B) Western analysis of SIRT6 protein in HeLa cells
stably expressing two independent SIRT6 shRNAs
(S6 sh1 and S6 sh2).
(C and D) SIRT6 inhibits TNF-a-induced (C) and
RELA-induced (D) reporter gene expression. RLU
of IL1-Luc (NF-kB reporter gene) activity (mean ±
SE) in control (pSR) and SIRT6 knockdown
(S6 sh2) HeLa cells is shown.
(E) Increased expression of NF-kB target genes in
SIRT6 knockdown cells. Quantitative TaqMan real-
time PCR analysis of the indicated mRNAs is
shown normalized to GAPDH levels (mean ± SE).
(F) Regulation of 18SIRT6-dependentNF-kB target
genes in six microarray data sets of human aging.
Each row is a data set; each column is a gene.
Significant induction (red) or repression (green)
with age (p < 0.05, one-sided t test) is shown. The
preponderance of age-dependent induction (81%
observed versus 50% expected) is significant (p =
0.001, hypergeometric distribution).
the premature senescence observed in
SIRT6 knockdown primary human fibro-
blasts (data not shown), which is due to
telomere dysfunction and H3K9 hyper-
acetylation at telomeric chromatin (Mich-
ishita et al., 2008). Together, these results
show that SIRT6 modulates apoptosis
resistance and telomere-independent
cellular senescence in human cells, via
inhibition of NF-kB.
Sirt6/ Tissues Exhibit Ectopic
Expression of NF-kB Target Genes
To examine the effects of SIRT6 defi-
ciency on NF-kB and potentially other
transcriptional regulators in vivo, we
carried out an unbiased screen for
transcriptional programs that are perturbed in Sirt6/ mice
compared to wild-type littermate controls (Figure 6A). We
harvested liver, spleen, thymus, and skin tissues from 21- to
29-day-old animals, and mouse embryonic fibroblasts (MEFs)
from day 13.5 embryos. For each tissue, RNA from wild-type
and Sirt6/ mice was subjected to competitive hybridization to
oligonucleotide microarrays. The RNA levels of hundreds of
genes were differentially expressed in each Sirt6/ versus
wild-type comparison (data not shown). We next applied cis-
regulatory motif analysis to identify candidate transcription
factors that are associated with the gene expression changes.
Previously, we have identified groupsof genes that share specific66 Cell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc.
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Figure 4. SIRT6 Deacetylates Histone H3K9 at Promoters of RELA Target Genes
(A) Western analysis of SIRT6 protein in HeLa cells stably expressing SIRT6 shRNA (sh2).
(B) SIRT6 is required for H3K9 deacetylation at promoters of RELA target genes. ChIP with a-H3K9Ac and a-H3 antibodies was performed. H3K9 acetylation at
RELA target gene promoters (mean ± SE) is shown relative to untreated control samples and normalized to total H3 levels.
(C) SIRT6 is required to limit RELA occupancy at the promoter of RELA target gene promoters. ChIP with a-RELA antibodies was performed following a 30 min
TNF-a pulse; RELA occupancy (mean ± SE) at promoters relative to untreated control samples is shown.
(D and E) SIRT6-mediated deacetylation of nucleosomes inhibits nucleosome binding to RELA. Western analysis of H3K9Ac levels on nucleosomes following
incubation with SIRT6 in NAD-dependent deacetylation or mock reactions (D). The acetylated or SIRT6-deacetylated nucleosomes were used in nucleosome
binding assays with increasing amounts of GST-RELA protein (E). The extent of nucleosome binding can be estimated by comparing levels of bound (**) and
unbound (*) nucleosomes. Reduced binding is observed in the SIRT6-deacetylated samples (compare 10 mg RELA samples).transcription factor binding motifs in their promoters, termed
motif modules (Adler et al., 2007). For instance, the NF-kB motif
module comprises genes that contain one or more NF-kBmotifs
in their promoters.Wehave constructed similarmotifmodules for
all known cis-regulatory motifs in single, double, or three-way
combinations. By comparing the genes showing altered expres-
sion in Sirt6/ tissues with the motif modules (Experimental
Procedures), we identified candidate motifs whose correspond-
ing genes showed a consistent change in expression in the
Sirt6/ tissues compared to wild-type controls (p < 0.05, hyper-geometric distribution). Many motif modules showed altered
expression in two or three Sirt6/ tissues. However, only 12
motif modules (including the NF-kB module) were induced, and
only 5 modules were repressed, in all seven Sirt6/ tissues
(Figure 6B). Three of these modules (AP2, STAT, MAZ) were
identified as being both induced and repressed in all tissues, indi-
cating that these are likely ‘‘noisy’’ motifs. Interestingly, fourmotif
modules (NF-kB, CEBP, LFA1, TEF) whose targets were induced
inSirt6/ tissueswere previously identified in a screen for candi-
date transcription factor motifs associated with gene expressionCell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc. 67
changes in mammalian aging (Adler et al., 2007). These analyses
provide in vivo evidence that SIRT6 deficiency leads to increased
expression of NF-kB-dependent genes.
We also directly compared gene expression patterns in
response to TNF-a in wild-type and Sirt6/ MEFs (Figure 6C).
Unsupervised hierarchical clustering identified a set of genes
whose expression differed between wild-type and Sirt6/
MEFs; many of these genes were enriched for NF-kB binding
sites in their promoters, or were previously shown to be induced
by NF-kB (Hinata et al., 2003; Hinz et al., 2001). Although the
kinetics of expression varied for specific genes, Sirt6 deficiency
was associated with an overall increase in NF-kB target gene
expression. In Figure 6C, the average expression level of the
genes in the cluster at each time point is shown. The most
dramatic increases in expression are observed following 24 hr
of TNF-a treatment.
We note that not all putative NF-kB target genes were hyper-
active in the SIRT6-deficient cells; rather, the SIRT6-regulated
NF-kB target genes were selectively enriched in several Gene
Ontology (Harris et al., 2004) terms related to immune response,
cell signaling, and metabolism (Figure 6C; Figure S7). Notably, in
ChIP analyses, SIRT6 was not detected at several of the NF-kB
target genes thatwere unaffected bySIRT6depletion (Figure S2).
Together, our results suggest that SIRT6 negatively regulates
expression of a subset of NF-kB target genes in vivo, by modi-
fying chromatin at the promoters of these genes.
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Figure 5. SIRT6 Alters NF-kB-Mediated Apoptosis
and Senescence
(A) SIRT6 regulates NF-kB-dependent apoptosis resis-
tance. pSR and S6 sh2 cells were transfected with the
indicated plasmids and a GFP expression plasmid. Trans-
fected (GFP-positive) apoptotic cells were identified by
nuclear morphology (DAPI staining; mean ± SE). Asterisks
indicate transfected, apoptotic cells. TUNEL analysis
confirmed that cells with pyknotic nuclei were undergoing
apoptosis (data not shown).
(B–D) RELA depletion reverses cellular senescence in
SIRT6-depleted primary human keratinocytes.
(B) Immunoblot of RELA and SIRT6 3 days after siRNA
nucleofection.
(C and D) Quantification of SA-b-gal-positive cells (C), as
shown in (D) (mean ± SE). *p < 0.0001 compared to all other
samples, Student’s t test.
RelA Heterozygosity Attenuates
Shortened Life Span and Aging-Related
Phenotypes of Sirt6/ Mice
To test whether excessive activation of NF-kB
may contribute to the phenotypes of Sirt6-defi-
cient mice, we examined Sirt6/ animals in
which RelA dosage is reduced. Sirt6+/ and
RelA+/ mice, both on the 129 genetic back-
ground, were crossed to create Sirt6+/RelA+/
progeny, which were then interbred to obtain
Sirt6/ animals with different dosages of RelA
(Figure 7A; Figure S6). We did not obtain any
Sirt6/RelA/ animals, as anticipated because
homozygous RelA deficiency is embryonically
lethal. Sirt6/RelA+/+ animals from these crosses exhibited
a phenotype identical to that of Sirt6/ mice (Mostoslavsky
et al., 2006). The Sirt6/RelA+/ mice also resembled Sirt6/
mice for the first 3 weeks of life, with lower body weight, blood
glucose, and serum IGF-1 levels compared to Sirt6-proficient
littermates (Figures 7D and 7F; Figure S6). However, in approx-
imately 40% of the Sirt6/RelA+/ animals, glucose and IGF-
1 levels eventually rose, growth resumed, and these individuals
survive (Figures 7C and 7F; Figure S6). Thus far, these rescued
Sirt6/RelA+/ animals have lived beyond 100 days and
appear healthy (Figures 7C, 7D, and 7F). In contrast to Sirt6/
animals, which exhibit profound lymphopenia and a 10-fold
reduction of spleen lymphocytes, the rescued Sirt6/RelA+/
animals also have relatively normal spleen size and lymphocyte
numbers (Figures 7G and 7H), and do not exhibit obvious lor-
dokyphosis (data not shown). Moreover, both male and female
Sirt6/RelA+/ mice are fertile, suggesting that the hypotha-
lamic-pituitary-gonadal endocrine system and germline stem
cell compartments are intact. Finally, microarray analysis
confirmed that RelA heterozygosity significantly reduces
the increased expression of genes in the NF-kB motif module
that was observed in Sirt6-deficient mice (Figure 7E;
Figure S7). Together, these data suggest that excessive NF-
kB-dependent gene expression contributes substantially to
the shortened life span and degenerative symptoms observed
in Sirt6/ mice.68 Cell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc.
Figure 6. Sirt6 Deficiency Leads to Ectopic Expression of NF-kB Target Genes In Vivo
(A) Schematic for unbiased screen for candidate transcriptional regulators of gene expression changes in Sirt6/ tissues.
(B) Motif modules induced or repressed in Sirt6/ tissues. Shown is the number of motifs that are induced or repressed in the indicated number of Sirt6/
tissues. The motif module of NF-kB was induced in all Sirt6/ tissues examined. Motifs labeled in gray were found to be both induced and repressed in all
Sirt6/ tissues in combination with different motifs. Asterisks indicate motifs previously implicated in a screen for transcription factor motifs responsible for
driving gene expression changes in mammalian aging (Adler et al., 2007). See Table S1 for motif modules induced or repressed upon Sirt6 knockout.
(C)Sirt6 knockout leads toNF-kB target gene induction. Shown is gene expression analysis in wild-type (WT) orSirt6/MEFs, following TNF-a treatment (20 ng/ml)
for the indicated times, of genes enriched for NF-kB motifs in promoters and known NF-kB-responsive genes (Hinata et al., 2003; Hinz et al., 2001). Note the
increased red (induced expression above control) genes in the SIRT6/ columns, particularly at 24 hr. Average expression of each column is shown at the top.DISCUSSION
SIRT6 Deacetylation of H3K9 Modulates
NF-kB-Dependent Gene Expression
Despite the dramatic phenotype of Sirt6-deficient mice, the
molecular mechanism underlying this phenotype has been
unclear, in part because of a lack of understanding of the funda-
mental mechanistic basis of SIRT6 function. In recent work, we
showed that SIRT6 deacetylates H3K9 at telomeric chromatinto prevent telomere dysfunction and cellular senescence (Mich-
ishita et al., 2008). However, defective telomeres are unlikely to
account for the phenotype of Sirt6 knockout mice, because of
the large functional reserve of telomeres in laboratory mouse
strains. In this context, no other genomic targets or chromatin
regulatory functions of SIRT6 have yet been described. In this
study, we have identified a new physiologic context for SIRT6
function as an H3K9 deacetylase. Our data show that SIRT6
negatively regulates NF-kB-dependent transcription via histoneCell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc. 69
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Figure 7. Haploinsufficiency of RelA Attenuates the Lethality and Aging-like Phenotypes of Sirt6-Deficient Mice
(A) Immunoblot showing reduced RelA protein levels in livers of Sirt6/RelA+/ animals compared to RelA+/+ animals.
(B) Photograph of 23-day-old Sirt6/RelA+/+ and Sirt6/RelA+/ littermates.
(C) Kaplan-Meier curve showing the survival of wild-type (n = 8), Sirt6/RelA+/+ (n = 6), and Sirt6/RelA+/ (n = 16) mice (p < 0.0007, Cox-Mantel log-rank test).
(D) Growth curve showing weight (grams; mean ± SE) of wild-type (n = 6), Sirt6/RelA+/+ (n = 7), and Sirt6/RelA+/ mice versus age in days. Sirt6/RelA+/
mice were categorized as survivors (n = 13) or nonsurvivors (n = 12) based on their ability to survive past 40 days.
(E) Excessive activation of the NF-kBmotif module in Sirt6/ spleen is attenuated in Sirt6/RelA+/ spleen. Shown is the fold induction (mean ± SE) of genes in
the NF-kB motif module, normalized to wild-type.70 Cell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc.
H3K9 deacetylation. To our knowledge, this finding constitutes
the first demonstration of a role for SIRT6 in gene expression
via the modulation of chromatin. We suggest that SIRT6 likely
also regulates gene expression via H3K9 deacetylation in addi-
tional physiologic contexts and, indeed, our computational
genomic analyses have identified several other gene expression
modules that are altered in Sirt6-deficient animals. Future
studies should determine whether these effects are also due to
direct Sirt6-dependent gene repression.
NF-kB stimuli such as TNF-a promote translocation of RELA to
the nucleus, where RELA associates with promoters of its target
genes. Our data suggest a model (Figure 7I) in which SIRT6 is re-
cruited to these genomic loci via a physical interactionwithRELA,
deacetylates histone H3K9, destabilizes RELA from chromatin,
and thereby contributes to NF-kB signal termination. As NF-kB
signaling controls expression of genes involved in apoptosis,
cellular senescence, inflammation, and immunity (Hardy et al.,
2005; Hoffmann and Baltimore, 2006), tight regulation of NF-kB
activity may be particularly important. Indeed, NF-kB activity is
controlled atmultiple levels, and several NF-kB regulatory factors
are themselves direct transcriptional targets of NF-kB which
contribute to negative feedback. Our findings further highlight
the importance of proper control of NF-kB signaling within the
nucleus for cell and organismal function, and place SIRT6 in the
growing class of negative regulators of NF-kB activity. Many
aspects of NF-kB regulation appear to be essential, as inactiva-
tion of a single mechanism, as shown here for SIRT6, can lead
to inappropriate NF-kB activation and disease. We note that
several NF-kB familymembers are among theRELA target genes
that show increased expression in SIRT6-deficient cells (Fig-
ure S4), and may contribute to the multiple layers of feedback
and complex dynamics of SIRT6-regulated gene expression
patterns.
Wenote that NF-kBRELA itself hasbeen reported to be subject
to regulationbyacetylation, and isdeacetylatedbyseveral deace-
tylases including SIRT1 (Chen and Greene, 2004; Yeung et al.,
2004). Although it is possible that SIRT6might also directlymodu-
late RELA acetylation levels, in our hands SIRT6 did not demon-
strate significant deacetylase activity on RELA in vitro or in cells
(Figure S5; data not shown). The fact that the SIRT1-RELA co-IP
is relatively weak could reflect the transient enzyme-substrate
nature of this interaction, whereas the SIRT6-RELA interaction,
which recruits SIRT6 to RELA target promoters, may be more
biochemically stable. SIRT1 and other non-sirtuin histone deace-
tylases may also contribute to modulation of the complex
dynamic patterns of histone acetylation at NF-kB target
promoters. However, unlike SIRT6, these deacetylases are not
specific for H3K9Ac. In this context, SIRT1 is a relatively promis-
cuous deacetylase with numerous histone substrates (Vaquero
et al., 2004). Interestingly, the association of SIRT1with chromatinat RELA target gene promoters (Yeung et al., 2004) occurs with
a completely different pattern from SIRT6. Moreover, in contrast
to our observations with SIRT6 inactivation, SIRT1 inactivation
by RNAi does not lead to changes in NF-kB target gene expres-
sion, except when cells are treated with resveratrol (Yeung
et al., 2004). Therefore, it appears that SIRT6 and SIRT1 impinge
upon NF-kB via distinct molecular mechanisms. It will be inter-
esting to determine whether these (and potentially other) SIRT
factors modulate NF-kB activity synergistically, or in distinct
nonoverlapping cell types or physiologic contexts.
SIRT6, NF-kB, and Longevity
Sirt6/ mice appear normal at birth, but by 3 weeks of age
exhibit a degenerative syndrome with features of premature
aging and succumb to death soon after (Mostoslavsky et al.,
2006). Using computational genomics, we have shown that
SIRT6deficiency leads to the activation ofmany of the same tran-
scriptional programs observed in aged tissues, including genes
controlled by NF-kB. This finding supports the idea that the
degenerative syndrome in Sirt6 knockout mice provides a physi-
ologically relevant model for aging-associated processes, albeit
with accelerated time course and exaggeration of certain
features.
Based on several findings, we propose that NF-kB deregula-
tion is a key factor contributing to the degenerative phenotypes
in Sirt6/ mice. First, elevated transcription of NF-kB targets
was observed in all Sirt6/ tissues analyzed, and these gene
expression abnormalities were attenuated by reduced RelA
dosage. Second, induction of cellular senescence and apoptosis
resistance by SIRT6 loss was rescued by simultaneous NF-kB
inhibition. Third, haploinsufficiency of RelA can extend the life
span of Sirt6-deficient mice tomore than 3months and attenuate
the degenerative phenotypes of Sirt6-deficient animals.
This genetic rescue is remarkable because Sirt6 or RelA defi-
ciency is individually lethal, and combining these alleles together
might be anticipated to make the animal more sick. Instead, the
early lethality and degenerative phenotypes caused bySirt6 defi-
ciency are substantially rescued by haploinsufficiency of RelA.
Together, our results suggest that excessive NF-kB activity is
required for Sirt6 deficiency to lead to disease.
Studies in yeast,worms, andflies have linkedSir2 factors to the
regulation of longevity (Guarente and Picard, 2005; Haigis and
Guarente, 2006). Intriguingly, the targets of sirtuins appear to
be distinct in different organisms, potentially reflecting different
molecular pathways that become limiting for organismal
longevity. InSaccharomyces cerevisiae, Sir2 prevents illegitimate
recombination at the ribosomal DNA locus and the formation of
presumably toxic extrachromosomal DNA circles (Sinclair and
Guarente, 1997). In Caenorhabditis elegans, life span extension
by Sir2.1 requires the IGF/FOXO pathway (Tissenbaum and(F) Serum glucose levels in wild-type (n = 6), Sirt6/RelA+/+ (n = 4), and Sirt6/RelA+/ mice (mean ± SE). Sirt6/RelA+/ mice were categorized as survivors
(n = 9) or nonsurvivors (n = 6) based on their ability to survive past 40 days; p values are indicated.
(G) Gross appearance of spleen from 122-day-old wild-type and Sirt6/RelA+/ mice.
(H) Hematoxylin and eosin (H&E) staining of spleen from wild-type and Sirt6/RelA+/ mice. The scale bar represents 100 mm.
(I) Model. NF-kB is a stress-responsive transcription factor that induces expression of target genes involved in aging-related processes including cell senes-
cence, apoptosis, and inflammation. NF-kB signaling is limited by SIRT6, which is recruited to NF-kB target gene promoters by physical interaction with the
NF-kB subunit RELA. SIRT6 deacetylates histone H3 lysine 9 on target gene promoters, thereby altering chromatin structure to facilitate NF-kB destabilization
and signal termination.
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Guarente, 2001). Mammalian SIRT6 also regulates metabolism
and IGF signaling, and Sirt6/ mice show severe metabolic
defects with hypoglycemia, low IGF-1, and low insulin levels
(Lombard et al., 2008; Mostoslavsky et al., 2006). Our results
show that these effects can be attenuated by haploinsufficiency
of NF-kB. Because sirtuins are NAD-dependent deacetylases,
SIRT6 may act as a nutrient or energy sensor, and may link
NF-kB signaling to the metabolic state of the organism. As
NF-kB is a crucial transcription factor implicated in a vast array
of disease states (Karin et al., 2004), its interaction with SIRT6
may provide a therapeutic target for these diseases, particularly
those associated with aging. SIRT6 protein expression appears
stable in young versus old mouse tissues (Figure S8). Given the
reported increase in NF-kB target gene activities that has been
observed with age, pharmacologic strategies to augment
SIRT6 activity may be promising approaches to attenuate exces-
sive NF-kB activity in such contexts.
Our study also highlights many intriguing questions. What are
the cell types in which NF-kB signaling orchestrates aging-asso-
ciated processes in Sirt6/ animals? How does signal termina-
tion by SIRT6 impact on the dynamic pattern and target selection
of NF-kB factors on a genome scale? Will the enhanced survival
of Sirt6/RelA+/ mice reveal additional aging-related or other
pathologic effects of SIRT6 deficiency? The viability of the
Sirt6/RelA+/ animals may provide a new model to study
mammalian aging and address these questions in the future.
EXPERIMENTAL PROCEDURES
Antibodies and Plasmids
Antibodies specific for FLAG (Sigma), RELA (Santa Cruz Biotechnology and Bi-
omol International), NF-kB family members (Santa Cruz Biotechnology), SIRT6
(Michishita et al., 2005; Abcam), SIRT1 (Upstate Biotechnology), T7 (Novagen),
H3K9Ac (Sigma), H3 (Abcam), b-ACTIN (Sigma), and TUBULIN (Upstate
Biotechnology) are from the indicated sources. FLAG-tagged SIRT4, SIRT5,
and SIRT6 are described (Michishita et al., 2005). FLAG-tagged SIRT1 wild-
type and HY mutant expression plasmids were generated by subcloning the
cDNAs from pYeSIR and pYeSIRHY (Vaziri et al., 2001) into p3x-FLAG (Sigma).
The GST-SIRT6 plasmid was generated by inserting the SIRT6 cDNA into
pGEX-6P1. T7-RELA (Chen et al., 2002) (W. Greene, UCSF), pCMVb-p300-
CHA (Eckner et al., 1994) (Y. Shi, Harvard University), pIL1b-Luc, pLZRS-
IkB-aM, and pCMV-RELA (P. Khavari, Stanford University), and pRK5-FADD
(Hsu et al., 1996) are as described and obtained from the indicated investiga-
tors. Site-directedmutations of SIRT6were generated by PCRmutagenesis as
previously described (Michishita et al., 2008). The pSR-S6sh1/S6sh2 plasmids
are described (Michishita et al., 2008). The RELA shRNA target sequence is
50-GATTGAGGAGAAACGTAAA-30.
Cell Culture and Retroviral Transduction
MEFs were generated from 13.5-day-old embryos using standard methods.
293T, HeLa, and HT1080 cells were from the ATCC and were propagated in
DMEM (Invitrogen) plus 10% fetal bovine serum. Primary human keratinocytes
were obtained from P. Khavari (Stanford University) and cultured in keratino-
cyte-SFM media (Invitrogen). Retroviral transduction was performed as
previously described (Michishita et al., 2008).
Immunoprecipitation Assays
Cells were lysed in IP lysis buffer (50 mM Tris-HCl [pH 7.4], 250 mM NaCl,
0.25% Triton X-100, 10% glycerol, complete protease inhibitor cocktail;
Roche). To reduce nonspecific binding, NaCl was added to 500 mM final
concentration, and the resulting extracts were incubated overnight with the
indicated IP antibodies. IP-antibody complexes were then captured on protein72 Cell 136, 62–74, January 9, 2009 ª2009 Elsevier Inc.A/G agarose beads (Pierce), and proteins were detected by western analysis.
In the case of FLAG IPs, agarose-conjugated anti-FLAG M2 monoclonal
antibodies (Sigma) were used.
GST Pull-Down Assays
RELA or SIRT6 sequences were in vitro transcribed and translated according
to the manufacturer’s instructions (Promega), and GST pull-down assays were
performed as previously described (Shi et al., 2006).
Reporter Gene Assays
293T cells were transfected with IL1-Luc, pRL-Luc, and FLAG-tagged SIRT
proteins. pSR control and S6 sh2 HeLa cells were transfected with IL1-Luc
and pRL-Luc and treated with TNF-a (10 ng/ml, 8 hr) or transfected with
pCMV-RELA or pcDNA3.1 (control). Dual luciferase assays (Promega) were
performed as described by the manufacturer.
Microarray Analyses
Total RNA was extracted with TRIzol (Invitrogen) from Sirt6-deficient or control
tissues or cells following TNF-a treatment (10 and 5 ng/ml, respectively) for the
indicated times. RNA from matched wild-type and knockout tissues were
labeled with Cy3 and Cy5, respectively, and competitively hybridized tomicro-
arrays. Mouse and human universal reference RNA (Stratagene) were used for
analysis of mouse and human cells, respectively. Construction and array
hybridization of human cDNA microarrays were performed as previously
described (Perou et al., 2000). Array hybridization of mouse MEEBO arrays
is as described (http://www.microarray.org/sfgf/meebo.do).
TNF-a Activation Time Course
Genes that were induced or repressed by at least 2-fold in any sample during
the time course were organized by hierarchical clustering (Eisen et al., 1998).
The main cluster that demonstrated increased induction in SIRT6-deficient
cells was highly enriched for NF-kB-responsive genes (Hinata et al., 2003;
Hinz et al., 2001) and genes possessing NF-kBmotifs (p < 103, hypergeomet-
ric distribution; Adler et al., 2007).
Motif Module Map
To analyze cis-regulatory motifs driving gene expression changes in Sirt6/
murine tissues, we identified genes that were induced or repressed by at least
a 1.5-fold change, and tested for their enrichment (p < 0.05, hypergeometric
distribution) for sets of genes that shared the presence of cis motifs, termed
motif modules (Adler et al., 2007). We then selected for motif modules that
were induced or repressed across multiple Sirt6/ tissues.
Regulation of Genes with Age
We determined whether 18 SIRT6-dependent NF-kB target genes (from
Figure S2) tended to be induced or repressed in an age-associated fashion
in six microarray data sets of human aging (compiled in Adler et al., 2007).
We calculated the Pearson correlation of the expression levels of each gene
to the age of the samples. Positive/negative correlation values were obtained
for genes whose expression level increased/decreased with age, respectively.
One-sided t tests (calculated with Winstat [R. Fitch Software, Germany]) were
used to determine the significance of each Pearson correlation.
Real-Time Quantitative RT-PCR
Total RNA was extracted from cells with TRIzol (Invitrogen). Total RNA (2 mg)
was reverse transcribedwith oligo(dT) primer using theSuperScript first-strand
synthesis system for RT-PCR (Invitrogen). Each PCR reaction contained first-
strand cDNA corresponding to 25 ng of RNA, TaqMan universal PCR master
mix, a set of primers and FAM/MGB probe for the gene of interest, and a set
of primers and VIC/MGB probe for humanGAPDH as the endogenous control.
All PCRprimers andTaqManprobeswere fromAppliedBiosystems. Reactions
were in triplicate for each sample and were analyzed using the ABI Prism 7300
sequence detection system. Data were normalized to GAPDH levels.
Chromatin Immunoprecipitation
Cells were treated with TNF-a (20 ng/ml) for the indicated times. DNA was
crosslinked for 10 min with 1% formaldehyde and stopped in 0.125 M glycine.
Purified chromatin was sonicated to 300 bp using the Bioruptor (Diagenode)
and incubated with the indicated antibodies. Following reverse crosslinking,
ChIP-associated sequences were detected by quantitative real-time PCR as
described above. PCR primer sequences for promoter regions are provided in
Table S2.
Nucleosome Binding Assay
Acetylated nucleosomes were obtained by size-exclusion chromatography of
micrococcal nuclease-digested chromatin isolated from HeLa cells, as
previously described (Shi et al., 2006), followed by incubation with p300/CBP
associated factor and acetyl-CoA. These nucleosomes were incubated with
purified SIRT6 protein in NAD-dependent deacetylation ormock reactions. Re-
combinant SIRT6 protein was previously described (Michishita et al., 2005).
The acetylated or SIRT6-deacetylated nucleosomes were used in nucleosome
binding assays with GST-RELA protein as previously described (Shi et al.,
2006).
Apoptosis and Senescence Assays
Cell Death
Cells were cotransfected with GFP-expressing plasmid (to identify transfected
cells) and either FADD or vector control in the presence or absence of IkB-aM
expression. After 30 hr, apoptotic GFP-expressing cells were identified based
on nuclear morphology (DAPI staining); TUNEL analysis confirmed that cells
with pyknotic nuclei were undergoing apoptosis (data not shown). The percent
apoptotic cells was determined by counting three separate fields for each
condition (minimum 100 transfected cells), and the data were normalized to
vector-expressing pSR cells.
Cellular Senescence
Primary human keratinocytes were transfected with 0.3 nmol siRNA against
SIRT6 (same target sequence as S6 sh2) and/or RELA (siGENOME smart
pool; Dharmacon) using the human keratinocyte Nucleofect kit (Amaxa
Biosystems). siGFP (Chi et al., 2003) was used as a negative control. Senes-
cence-associated b-galactosidase (SA-b-gal) activity was detected with an
SA-b-gal staining kit (Cell Signaling Technology) after 6 days. Blue cells
were counted in ten 103 fields of equally dense cells. Similar results were
obtained using 0.75 nmol siRNA (data not shown).
Generation of Sirt6/RelA+/ Mice
Sirt6/ (Mostoslavsky et al., 2006) andRelA+/ (Beg et al., 1995) mice were as
described. Sirt6+/ and RelA+/ mice were crossed, and Sirt6+/RelA+/
progeny were interbred to obtain Sirt6/RelA+/ mice. Kaplan-Meier survival
curves were compared by the Cox-Mantel log-rank test in Winstat for Excel
(R. Fitch Software).
Glucose Measurements
Serum glucose was measured from tail blood using the Ascensia contour
blood glucose monitoring system following the manufacturer’s instructions.
URLs
Full microarray data are available for download at the Stanford Microarray
Database (http://genome-www5.stanford.edu) andGeneExpressionOmnibus
(http://www.ncbi.nlm.nih.gov/geo).
SUPPLEMENTAL DATA
Supplemental Data include eight figures and two tables and can be
found with this article online at http://www.cell.com/supplemental/S0092-
8674(08)01446-3.
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